Biological E. Ltd
- All
- News
-
100 Million Corbevax Doses Supplied To Centre, Says Biological E
Biological E. Ltd (BE) on Thursday said it has delivered 10 crore (100 million) doses of its COVID-19 vaccine, Corbevax, to the Centre so far.
-
India's Biological E, US Finalise $50 Million Covid Vaccine Deal: Report
The United States and India's Biological E. Ltd said on Monday they had finalised a financing arrangement for $50 million to expand the vaccine maker's capacity to produce COVID-19 shots.
-
US To Finance India's Biological E In $50 Million Covid Vaccine Deal
The United States and India's Biological E. Ltd said on Monday they had finalised a financing arrangement for $50 million to expand the vaccine maker's capacity to produce COVID-19 shots.
-
Hyderabad-Based Firm Biological E Starts Human Trials Of Covid Vaccine Candidate
Biological E. Ltd has started human trials of its COVID-19 vaccine candidate and expects results by February, the drugmaker said on Monday.
-
Bill Gates makes hush-hush visits to firms in Andhra Pradesh
Microsoft co-founder and chairman Bill Gates visited Biological E. Ltd, a leading vaccine manufacturer, and the International Crops Research Institute for Semi Arid Tropics (ICRISAT) near Hyderabad on Thursday on a private trip kept completely under wraps.
-
100 Million Corbevax Doses Supplied To Centre, Says Biological E
Biological E. Ltd (BE) on Thursday said it has delivered 10 crore (100 million) doses of its COVID-19 vaccine, Corbevax, to the Centre so far.
-
India's Biological E, US Finalise $50 Million Covid Vaccine Deal: Report
The United States and India's Biological E. Ltd said on Monday they had finalised a financing arrangement for $50 million to expand the vaccine maker's capacity to produce COVID-19 shots.
-
US To Finance India's Biological E In $50 Million Covid Vaccine Deal
The United States and India's Biological E. Ltd said on Monday they had finalised a financing arrangement for $50 million to expand the vaccine maker's capacity to produce COVID-19 shots.
-
Hyderabad-Based Firm Biological E Starts Human Trials Of Covid Vaccine Candidate
Biological E. Ltd has started human trials of its COVID-19 vaccine candidate and expects results by February, the drugmaker said on Monday.
-
Bill Gates makes hush-hush visits to firms in Andhra Pradesh
Microsoft co-founder and chairman Bill Gates visited Biological E. Ltd, a leading vaccine manufacturer, and the International Crops Research Institute for Semi Arid Tropics (ICRISAT) near Hyderabad on Thursday on a private trip kept completely under wraps.
